Nurix Therapeutics (NRIX) Amortizatization of Intangibles (2020 - 2026)
Nurix Therapeutics (NRIX) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $1.6 million as the latest value for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 55.58% to $1.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.3 million through Feb 2026, down 35.82% year-over-year, with the annual reading at $10.3 million for FY2025, 8.56% down from the prior year.
- Amortizatization of Intangibles for Q1 2026 was $1.6 million at Nurix Therapeutics, down from $1.9 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $4.2 million in Q3 2024, with the low at -$4.5 million in Q4 2022.
- Average Amortizatization of Intangibles over 5 years is $1.7 million, with a median of $1.8 million recorded in 2023.
- Peak annual rise in Amortizatization of Intangibles hit 1016.86% in 2022, while the deepest fall reached 623.68% in 2022.
- Over 5 years, Amortizatization of Intangibles stood at -$4.5 million in 2022, then skyrocketed by 140.81% to $1.8 million in 2023, then surged by 91.61% to $3.5 million in 2024, then plummeted by 46.55% to $1.9 million in 2025, then decreased by 15.37% to $1.6 million in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $1.6 million, $1.9 million, and $3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.